BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2037 related articles for article (PubMed ID: 10095413)

  • 1. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
    Deckert-Schlüter M
    Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis.
    Deckert-Schlüter M; Bluethmann H; Rang A; Hof H; Schlüter D
    J Immunol; 1998 Apr; 160(7):3427-36. PubMed ID: 9531303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation.
    Deckert-Schlüter M; Rang A; Weiner D; Huang S; Wiestler OD; Hof H; Schlüter D
    Lab Invest; 1996 Dec; 75(6):827-41. PubMed ID: 8973478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma receptor-mediated but not tumor necrosis factor receptor type 1- or type 2-mediated signaling is crucial for the activation of cerebral blood vessel endothelial cells and microglia in murine Toxoplasma encephalitis.
    Deckert-Schlüter M; Bluethmann H; Kaefer N; Rang A; Schlüter D
    Am J Pathol; 1999 May; 154(5):1549-61. PubMed ID: 10329607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.
    Schlüter D; Kwok LY; Lütjen S; Soltek S; Hoffmann S; Körner H; Deckert M
    J Immunol; 2003 Jun; 170(12):6172-82. PubMed ID: 12794148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
    Yap GS; Sher A
    J Exp Med; 1999 Apr; 189(7):1083-92. PubMed ID: 10190899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.
    Gazzinelli RT; Eltoum I; Wynn TA; Sher A
    J Immunol; 1993 Oct; 151(7):3672-81. PubMed ID: 7690809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii.
    Caamaño J; Tato C; Cai G; Villegas EN; Speirs K; Craig L; Alexander J; Hunter CA
    J Immunol; 2000 Nov; 165(10):5720-8. PubMed ID: 11067930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of the intracerebral and splenic cytokine mRNA production in Toxoplasma gondii-resistant and -susceptible congenic strains of mice.
    Deckert-Schlüter M; Albrecht S; Hof H; Wiestler OD; Schlüter D
    Immunology; 1995 Jul; 85(3):408-18. PubMed ID: 7558129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of major histocompatibility complex class II antigens and levels of interferon-gamma, tumour necrosis factor, and interleukin-6 in cerebrospinal fluid and serum in Toxoplasma gondii-infected SCID and immunocompetent C.B-17 mice.
    Schlüter D; Deckert-Schlüter M; Schwendemann G; Brunner H; Hof H
    Immunology; 1993 Mar; 78(3):430-5. PubMed ID: 8478025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.
    Kang H; Remington JS; Suzuki Y
    J Immunol; 2000 Mar; 164(5):2629-34. PubMed ID: 10679102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
    Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
    J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal gp130 expression is crucial to prevent neuronal loss, hyperinflammation, and lethal course of murine Toxoplasma encephalitis.
    Händel U; Brunn A; Drögemüller K; Müller W; Deckert M; Schlüter D
    Am J Pathol; 2012 Jul; 181(1):163-73. PubMed ID: 22640806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MyD88 is crucial for the development of a protective CNS immune response to Toxoplasma gondii infection.
    Torres M; Guiton R; Lacroix-Lamandé S; Ryffel B; Leman S; Dimier-Poisson I
    J Neuroinflammation; 2013 Feb; 10():19. PubMed ID: 23374751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues.
    Fujigaki S; Takemura M; Hamakawa H; Seishima M; Saito K
    Adv Exp Med Biol; 2003; 527():97-103. PubMed ID: 15206721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.
    Gazzinelli RT; Wysocka M; Hieny S; Scharton-Kersten T; Cheever A; Kühn R; Müller W; Trinchieri G; Sher A
    J Immunol; 1996 Jul; 157(2):798-805. PubMed ID: 8752931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo.
    Yap GS; Scharton-Kersten T; Charest H; Sher A
    J Immunol; 1998 Feb; 160(3):1340-5. PubMed ID: 9570552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis.
    Brown CR; Hunter CA; Estes RG; Beckmann E; Forman J; David C; Remington JS; McLeod R
    Immunology; 1995 Jul; 85(3):419-28. PubMed ID: 7558130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function.
    Yap GS; Sher A
    Immunobiology; 1999 Dec; 201(2):240-7. PubMed ID: 10631573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of systemic cytokine and brain chemokine gene expression in murine toxoplasma infection.
    Aviles H; Stiles J; O'Donnell P; Orshal J; Leid J; Sonnenfeld G; Monroy F
    J Parasitol; 2008 Dec; 94(6):1282-8. PubMed ID: 19127964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 102.